New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment
Open Access
Abstract
Immunometabolism is an emerging discipline in cancer immunotherapy. Tumor tissues are heterogeneous and influenced by metabolic reprogramming of the tumor immune microenvironment (TIME). In the TIME, multiple cell types interact, and the tumor and immune cells compete for limited nutrients, resulting in altered anticancer immunity. Therefore, metabolic reprogramming of individual cell types may influence the outcomes of immunotherapy. Understanding the metabolic competition for access to limited nutrients between tumor cells and immune cells could reveal the breadth and complexity of the TIME and aid in developing novel therapeutic approaches for cancer. In this review, we highlight that, when cells compete for nutrients, the prevailing cell type gains certain advantages over other cell types; for instance, if tumor cells prevail against immune cells for nutrients, the former gains immune resistance. Thus, a strategy is needed to selectively suppress such resistant tumor cells. Although challenging, the concept of cell type-specific metabolic pathway inhibition is a potent new strategy in anticancer immunotherapy.Keywords
Funding Information
- Korea Health Industry Development Institute (HI14C1324)
This publication has 164 references indexed in Scilit:
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiationNature Immunology, 2013
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B CellsCell Metabolism, 2012
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsJournal of Experimental Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The role of tumour-derived iNOS in tumour progression and angiogenesisBritish Journal of Cancer, 2010
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010
- Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activationBlood, 2010
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and CysteineCancer Research, 2010
- Regulatory T Cells Reinforce Intestinal HomeostasisImmunity, 2009